These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7694457)

  • 1. Recombinant cytokines and pulmonary host defense.
    Kolls JK; Nelson S; Summer WR
    Am J Med Sci; 1993 Nov; 306(5):330-5. PubMed ID: 7694457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity, cytokines, and pulmonary host defense.
    Nelson S; Summer WR
    Infect Dis Clin North Am; 1998 Sep; 12(3):555-67, vii. PubMed ID: 9779378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in host defense against pneumonia.
    Standiford TJ; Huffnagle GB
    J Investig Med; 1997 Aug; 45(6):335-45. PubMed ID: 9291689
    [No Abstract]   [Full Text] [Related]  

  • 4. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and pulmonary host defenses.
    Standiford TJ
    Curr Opin Pulm Med; 1997 Mar; 3(2):81-8. PubMed ID: 9193851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor necrosis factor and colony-stimulating factors in phagocyte function against Candida albicans.
    Djeu JY
    Diagn Microbiol Infect Dis; 1990; 13(5):383-6. PubMed ID: 2126496
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of cytokines.
    Talmadge JE; Black PL
    Adv Exp Med Biol; 1988; 233():395-403. PubMed ID: 3146903
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
    Chelstrom LM; Finnegan D; Uckun FM
    Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
    Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
    J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates.
    Uddin M; Betts C; Robinson I; Malmgren A; Humfrey C
    Haematologica; 2017 Feb; 102(2):e65-e68. PubMed ID: 27742769
    [No Abstract]   [Full Text] [Related]  

  • 14. Mucosal administration of flagellin induces innate immunity in the mouse lung.
    Honko AN; Mizel SB
    Infect Immun; 2004 Nov; 72(11):6676-9. PubMed ID: 15501801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host innate defenses in the lung: the role of cytokines.
    Strieter RM; Belperio JA; Keane MP
    Curr Opin Infect Dis; 2003 Jun; 16(3):193-8. PubMed ID: 12821807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.
    Katragkou A; Simitsopoulou M; Chatzimoschou A; Georgiadou E; Walsh TJ; Roilides E
    Cytokine; 2011 Sep; 55(3):330-4. PubMed ID: 21641233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
    Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
    J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ethanol, tumor necrosis factor, and granulocyte colony-stimulating factor on lung antibacterial defenses.
    Nelson S; Bagby G; Andresen J; Nakamura C; Shellito J; Summer W
    Adv Exp Med Biol; 1991; 288():245-53. PubMed ID: 1719751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in patients with systemic mycoses: a promising adjunct.
    Farmaki E; Roilides E
    BioDrugs; 2001; 15(4):207-14. PubMed ID: 11437686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.